The early diagnosis and differential diagnosis of Alzheimer's disease with clinical methods;Az Alzheimer-dementia korai felismerése és differenciáldiagnózisa klinikai vizsgálómódszerekkel

Orvosi Hetilap

Volumn 149, Issue 51, 2008, Pages 2433-2440

  Égerházi, Anikó ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Alzheimer's disease; Apoptosis; Neuropsychology; P300; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ACTIVITY; EVOKED AUDITORY RESPONSE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PAIRED ASSOCIATE LEARNING; PREDICTION; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY ANALYSIS;

EID: 58349108895     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28429     Document Type: Article

References (44)

1. Birks, J.: Cholinesterase inhibitors for Alzheimer's disease. The Cochrane Library, 2006, No. 1. (Cd 005593) Source Notes: Updated Online or Cd-Rom, Updated Quarterly. Issn: 1464-780x.
2. Ritchie, C. W.: Meta-analysis of randomised trials of the efficacy and safety of donepesil, galantamin and rivastigmin for the treatment of Alzheimer's disease. Am. J. Geriat. Psychiat., 2004, 12, 338-369.
3. Braak, H., Braak, E.: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol., 1991, 82, 239-259.
4. Petersen, R. C., Doody, R., Kurz, A. és mtsai: Current concepts in mild cognitive impairment. Arch. Neurol., 2001, 58, 1985-1992.
5. Petersen, R. C., Smith, G. E., Waring, S. C. és mtsai: Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol., 1999, 56, 303-308.
6. Petersen, R. C., Stevens, J. C., Ganguli, M. és mtsai: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology, 2001, 56, 1133-1142.
7. Snowdon, D. A.: Healthy aging and dementia: Findings from the Nun Study. Ann. Intern. Med., 2003, 139, 450-454.
8. DeCarli, C.: Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol., 2003, 2, 15-21.
9. O'Brien, J. T., Erkinjuntti, T., Reisberg, B. és mtsai: Vascular cognitive impairment. Lancet Neurol., 2003, 2, 89-98.
10. Janzing, J. G. E.: Depression and dementia: missing the link. Curr. Op. Psych., 2003, 16, 13-16.
11. Twamley, E. W., Ropacki, S. A., Bondi, M. W.: Ncuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J. Int. Neuropsychol. Soc., 2006, 12, 707-735.
12. Weiland-Fiedler, P., Erickson, K., Waldeck, T. és mtsai: Evidence for continuing neuropsychological impairments in depression. J. Affect. Discord., 2004, 82, 253-258.
13. Rajna, P., Hidasi, Z, Szelenberger, W.: Event-related EEG and evoked potential investigations in the clinical practice. Clin. Neurosci./Ideggy. Szle., 2005, 58, 380-392.
14. Polich, J., Herbst, K. L.: P300 as a clinical assay: rationale, evaluation, and findings. Int. J. Psychophysiol., 2000, 38, 3-19.
15. Janka, Z, Juhász, A., Rimanóczy, Á és mtsai: Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol. Psychiat., 2002, 7, 110-112.
16. Fésüs, L., Tarcsa, E., Kedei, N. és mtsai: Degradation of cells by apoptosis leads to accumulation of E(γ-glutamyl)lysine isodipeptide in culture fluid and blood. FEBS Lett., 1991, 284, 109-112.
17. ICD-10: The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. WHO, Geneva, 1993.
18. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, D.C., 1994.
19. McKhann, G., Drachman, D., Folstein, M. és mtsai: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 1984, 3, 939-944.
20. Roman, G. C., Tatémicbi, T., Erkinjuntti, T. és mtsai: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43, 250-260.
21. Tariska, P., Bereczki, D., Degrell, I. és mtsai: Ajánlás a demenciák kivizsgálására és kezelésére. Psych. Hung., 2002, 17, 202-223.
22. Pszichiátriai Szakmai Kollégium: A dementia kórismézése, kezelése és gondozása. Az Egészségügyi Minisztérium szakmai protokollja. Egészségügyi Közlöny, 2006, 5.
23. Hachinski, V. C., Iliff, L. D., Zilhka, E.: Cerebral blood flow in dementia. Arch. Neurol., 1975, 32, 632-637.
24. Folstein, M. F., Folstein, S. E., McHugh, P. R.: "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J. Psychiatr. Res., 1975, 12, 189-198.
25. Shulman, K. I., Gold, D. P., Cohen, C. A. és mtsai: Clock drawing and dementia in the community: A longitudinal study. Int. J. Geriat. Psychiat., 1993, 8, 487-496.
26. Berg, L.: Clinical Dementia Rating. Psychopharmacol. Bull., 1988, 24, 637-639.
27. Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 1960, 23, 56-62.
28. Bartók E., Berecz R., Glaub T. és mtsa: Számitógépes neurokognitív vizsgálati programcsomag magyarországi validálása. Validation of the computerized neurocognitive test battery [CANTAB] in Hungary. Psychiatr. Hung., 2001, 16, 125-133.
29. Paragh, Gy., Balla, P., Katon, E. és mtsai: Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci., 2002, 252, 63-67.
30. Nemes, Z., Fésüs, L., Égerházi, A. és mtsai: N(epsilon)(gammaglutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol. Aging, 2001, 22, 403-406.
31. Égerházi, A., Berecz, R., Bartók, E. és mtsa: Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 2007, 31, 746-751.
32. Jakala, P., Sirvio, J., Riekkinen, M. és mtsai: Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology, 1999, 20, 119-130.
33. Lichtenberg, P. A., Ross, T., Millis, S. R. és mtsa: The relationship between depression and cognition in older adults: a cross validation study. J. Gerontol. B. Psychol. Sci. Soc. Sci., 1995, 50, 25-32.
34. Antonova, E., Sharma, T., Morris, R. és mtsa: The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res., 2004, 70, 117-145.
35. Twamley, E. W., Ropacki, S. A., Bondi, M. W.: Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J. Int. Neuropsychol. Soc., 2006, 12, 707-735.
36. Fowler, K. S., Saling, M. M., Conway, E. L. és mtsai: Paired associate performance in the early detection of DAT. J. Int. Neuropsychol. Soc., 2002, 8, 58-71.
37. Owen, A. M., Sahakian, B. J., Semple, J. és mtsai: Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia, 1995, 33, 1-24.
38. Johnsrude, I. S., Owen, A. M., Crane, J. és mtsai: A cognitive activation study of memory for spatial relationships. Neuropsychologia, 1999, 37, 829-841.
39. Bemelmans, K. J., Goekoop, J. G., van Kempen, G. M.: Recall performance in acutely depressed patients and plasma cortisol. Biol. Psychiat., 1996, 39, 750-752.
40. Günther, W., Giunta, R., Klages, U. és mtsai: Findings of electro-encephalographic brain mapping in mild to moderate dementia of the Alzheimer type during resting, motor, and music-perceptions. Psychiat. Res., 1993, 50, 163-176.
41. Polich, J., Herbst, K. L.: P300 as a clinical assay: rationale, evaluation, and findings. Int. J. Psychophysiol., 2000, 38, 3-19.
42. Maurer, K., Dierks, T.: Finding in diseases. In: Atlas of Brain Mapping. Szerk.: Maurer, K. Berlin, Heidelberg, Springer-Verlag, 1991, 54-88.
43. Korf, E. S. C., Wablund, L. O., Visser, P. J. és mtsa: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology, 2004, 63, 94-100.
44. den Heijer, T., Sijens, P. E., Prins, N. D. és mtsai: MR spectroscopy of brain white matter in the prediction of dementia. Neurology, 2006, 66, 540-544.